http://media.marketwire.com/attachments/201012/16870_Cytori_Logo_RGB.gifhttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=890586&ProfileId=051205&sourceType=1SAN DIEGO, CA -- (Marketwire) -- 05/23/12 -- Cytori Therapeutics (NASDAQ: CYTX) will present and provide a corporate update from the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 10:00 AM ET.
The presentation will be webcast and may be accessed under "Webcasts" on Cytori's Investor Relations website (ir.cytori.com). The webcast can be viewed live and will be available for replay after the presentation on the Company's website.
About Cytori
Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the immune response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family. www.cytori.com
Contact:
Megan McCormick
mmccormick@cytori.com
858.875.5279